Table 4 Normal tissue complication probability under the same prescription for uterine tandem imperfect implantation (`x ± s).

From: Dosimetric and clinical outcomes study of occult uterine tandem imperfect implantation in HDR-brachytherapy for cervical cancer

 

Inadequate implantation (n = 12)

Anterior wall (n = 11)

Posterior wall (n = 9)

Fundus perforation (n = 6)

PER-3D vs IM-3D

PER-2D vs IM-2D

PER-3D vs IM-3D

PER-2D vs IM-2D

PER-3D vs IM-3D

PER-2D vs IM-2D

PER-3D vs IM-3D

PER-2D vs IM-2D

TCP (%)

6.02 ± 9.88

24 ± 21.91*

8.04 ± 10.14*

29.75 ± 23.91

4.62 ± 3.62

12.29 ± 23.15*

2.20 ± 2.01*

2.75 ± 5.67*

NTCP (%)

 Bladder

− 8.17 ± 23.13

0.31 ± 3.63*

− 26.99 ± 44.11

-0.21 ± 2.49

− 11.11 ± 31.31

2.68 ± 3.63

− 0.15 ± 0.29

0.06 ± 1.29

 Rectum

− 60.46 ± 39.28*

5.43 ± 34.28

− 32.12 ± 44.58*

2.83 ± 56.04

− 41.60 ± 47.16*

− 18.68 ± 42.36

− 1.88 ± 3.05

− 20.33 ± 72.13

 Sigmoid

− 35.52 ± 31.93*

7.97 ± 34.11

− 19.05 ± 36.85

27.11 ± 21.71*

− 22.56 ± 24.56*

− 13.37 ± 31.72

− 19.35 ± 30.58

− 21.18 ± 31.15

 Intestines

− 33.21 ± 29.06*

− 8.99 ± 45.62

− 41.28 ± 34.31*

− 35.49 ± 42.25*

− 24.78 ± 36.86

− 6.37 ± 41.47

− 4.16 ± 5.87

− 7.12 ± 39.26

  1. IM: Imperfect insertions, PER: Perfect insertions, 3D: three-dimensional treatment plan, 2D: two-dimensional treatment plan.
  2. *This is statistically significant, p < 0.05.
Back to article page